Implications of Health Equity for Children With Disabilities
This Viewpoint discusses how the National Institutes of Health designation of individuals with disabilities as a health disparity population can boost research participation and funding and expand health care access for pediatric patients with disabilities. (Source: JAMA Pediatrics)
Source: JAMA Pediatrics - April 29, 2024 Category: Pediatrics Source Type: research
The Pediatric Surgeon-Scientist: An Evolving Breed or Endangered Phenotype?
National Institute of Health (NIH) funding is a “gold-standard” of achievement; we examined trends in NIH-funded pediatric surgeons. (Source: American Journal of Surgery)
Source: American Journal of Surgery - April 29, 2024 Category: Surgery Authors: Nikhil R. Shah, Keerthi Burgi, Dimitra M. Lotakis, Niki Matusko, Erika A. Newman, Samir K. Gadepalli Source Type: research
IJERPH, Vol. 21, Pages 565: A Mixed-Methods Evaluation to Inform the Hawai & #699;i Suicide Prevention Strategic Plan
IJERPH, Vol. 21, Pages 565: A Mixed-Methods Evaluation to Inform the Hawaiʻi Suicide Prevention Strategic Plan
International Journal of Environmental Research and Public Health doi: 10.3390/ijerph21050565
Authors:
Saikaew Dudla
Tarin T. Tanji
Jeanelle Sugimoto-Matsuda
Jane J. Chung-Do
Eric Agluba
Tricia Khun
Shivani Trivedi
Deborah Goebert
The Prevent Suicide Hawaiʻi Taskforce is a state, public, and private partnership of individuals, organizations, and community groups that leads statewide suicide prevention efforts in Hawaiʻi. The purpose of this evaluation was to...
Source: International Journal of Environmental Research and Public Health - April 29, 2024 Category: Environmental Health Authors: Saikaew Dudla Tarin T. Tanji Jeanelle Sugimoto-Matsuda Jane J. Chung-Do Eric Agluba Tricia Khun Shivani Trivedi Deborah Goebert Tags: Article Source Type: research
Access for all: Research at the National Abortion Federation ’s 47th Annual Meeting
It has been almost 2 years since the Dobbs v. Jackson Women ’s Health Organization decision was handed down resulting in sweeping abortion restrictions and bans in nearly half of the United States. However, the demand for abortion remains unchanged, and, despite restrictions, the number of abortions in the United States has remained steady [1]. Increased funding and support in states that remain friendly to abortion seekers, telemedicine abortion care, shield law provision, and increased public awareness about abortion access have all helped people get the care they need. (Source: Contraception)
Source: Contraception - April 29, 2024 Category: OBGYN Authors: Alice Mark, Angel M. Foster, Gabriela Aguilar, Tiffany Hailstorks, Rachel K. Jones, Melissa Madera, Sarah W. Prager Source Type: research
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial
Lancet Respir Med. 2024 Apr 25:S2213-2600(24)00079-1. doi: 10.1016/S2213-2600(24)00079-1. Online ahead of print.ABSTRACTBACKGROUND: Systematic reviews have reported conflicting evidence on whether macrolide antibiotics reduce rates of chronic lung disease of prematurity (CLD) in at-risk preterm infants born at less than 30 weeks' gestation, including in those colonised with pulmonary Ureaplasma spp. Since an adequately powered trial has been lacking, we aimed to assess if the macrolide azithromycin improved survival without the development of physiologically defined moderate or severe CLD in preterm infants.METHODS: AZTEC ...
Source: Respiratory Care - April 28, 2024 Category: Respiratory Medicine Authors: John Lowe David Gillespie Ali Aboklaish Tin Man Mandy Lau Claudia Consoli Malavika Babu Mark Goddard Kerenza Hood Nigel Klein Emma Thomas-Jones Mark Turner Marie Hubbard Julian Marchesi Janet Berrington Sailesh Kotecha Source Type: research
Erratum to: “Racial Disparities in Opioid Use and Lumbar Spine Surgery for Chronic Pain and in Pain and Function Over 3 Years: A Retrospective Cohort Study,” The Journal of Pain, Volume 25, Issue 3, March 2024, Pages 659-671
The publisher regrets an incorrect disclosure was added to the manuscript Racial Disparities in Opioid Use and Lumbar Spine Surgery for Chronic Pain and in Pain and Function Over 3 Years: A Retrospective Cohort Study. National Institutes of Health funding does not pertain to the research, and the text was added during the production process after the author's final review of the proof. The incorrect disclosure text has been removed, and the authors have no disclosures. The publisher would like to apologize for any inconvenience caused. (Source: The Journal of Pain)
Source: The Journal of Pain - April 27, 2024 Category: Materials Science Authors: John C. Licciardone, Chase L. Miller, Alex J. Nazzal, Christian T. Hernandez, Linh H. Nguyen, Subhash Aryal Source Type: research
Evolution of public funding since primary care research was considered as a priority research domain in france
Annually, the French Ministry of Health funds clinical research projects based on a national call for projects. Since 2013, the Ministry has prioritized funding of primary care. Projects selected for funding a... (Source: BMC Family Practice)
Source: BMC Family Practice - April 27, 2024 Category: Primary Care Authors: Jordan Scheer, Taylor Leroy, Sylvie Guillo, Florence Tubach, Antoine Roz ès, Amandine Verga-Gérard, Francis Guillemin, Maryse Lapeyre-Mestre and Anthony Chapron Tags: Research Source Type: research
Vitamin A supplementation coverage and associated factors for children aged 6 to 59 months in integrated and campaign-based delivery systems in four sub-Saharan African countries
Vitamin A deficiency (VAD) is a leading contributor to the poor health and nutrition of young children in sub-Saharan Africa. Funding constraints are compelling many countries to shift from longstanding campai... (Source: BMC Public Health)
Source: BMC Public Health - April 27, 2024 Category: Consumer Health News Authors: Amynah Janmohamed, David Doledec, Romance Dissieka, Umu H. Jalloh, Sugandh Juneja, Maguette Beye, Fatou Ndiaye, Theresia Jumbe and Melissa M. Baker Tags: Research Source Type: research
Cancers, Vol. 16, Pages 1708: Prognosis and Treatment of Gastric Cancer: A 2024 Update
l Samasca
Due to the high death rate associated with gastric cancer, a great deal of research has been conducted on this disease. The goal of this paper was to start a trimestral review of 2024 for the year that had just started. The scientific literature from 1 January 2024 was chosen with consideration of the the guidelines of the European Society of Medical Oncology (ESMO), which are updated with new findings but not systematically reviewed annually. We used the search term “gastric cancer” to find the most current publications in the PubMed database related to the prognosis and treatment...
Source: Cancers - April 27, 2024 Category: Cancer & Oncology Authors: Claudia Burz Vlad Pop Ciprian Silaghi Iulia Lupan Gabriel Samasca Tags: Review Source Type: research
The role of helplines in the anti-trafficking space: examining contacts to a major ‘modern slavery’ hotline
We examined who seeks help, why and what follows. Contrary to stereotypes, relatively few cases involved sexual exploitation. Many case characteristics varied significantly by exploitation type. Reports about car washes and beauty services heavily influenced overall trends, likely reflecting intense public focus on these sites. Most cases involved adults. Although people self-reporting exploitation are the core target au dience, only around 1 in 10 cases derived from self-reports (with higher rates for domestic servitude). We show how third-party reporters vary in their proximity to the people about whom they raise conce...
Source: Crime, Law and Social Change - April 27, 2024 Category: Criminology Source Type: research
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141.ABSTRACTMulti-criteria decision analysis (MCDA) is a value assessment tool designed to help support complex decision-making by incorporating multiple factors and perspectives in a transparent, structured approach. We developed an MCDA rating tool, consisting of seven criteria evaluating the importance and feasibility of conducting potential real-world evidence (RWE) studies aimed at addressing uncertainties stemming from initial cancer drug funding recommendations. In collaboration with the Canadian Agency for Drugs and Technologies in Health's Provinci...
Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Pam Takhar Marc Geirnaert Scott Gavura Jaclyn Beca Rebecca E Mercer Avram Denburg Caroline Mu ñoz Mina Tadrous Ambica Parmar Francois Dionne Darryl Boehm Carole Chambers Erica Craig Maureen Trudeau Matthew C Cheung Joanne Houlihan Valerie McDonald Petros Source Type: research
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
Curr Oncol. 2024 Mar 29;31(4):1803-1816. doi: 10.3390/curroncol31040136.ABSTRACTPatient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, health technology assessment (HTA) and collective government price negotiation. These steps delay access and prevent health care providers from being able to prescribe optimal therapy. Eighteen Canadian oncology clinicians from the medicine, nursing and pharmacy professions met to develop consensus recommendations for defining reasonable government performance standards around process and ti...
Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Sandeep R Sehdev Nigel S B Rawson Olexiy I Aseyev Catriona J Buick Marcus O Butler Scott Edwards Sharlene Gill Joanna M Gotfrit Cyrus C Hsia Rosalyn A Juergens Mita Manna Joy S McCarthy Som D Mukherjee Stephanie L Snow Silvana Spadafora David J Stewart Ja Source Type: research
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141.ABSTRACTMulti-criteria decision analysis (MCDA) is a value assessment tool designed to help support complex decision-making by incorporating multiple factors and perspectives in a transparent, structured approach. We developed an MCDA rating tool, consisting of seven criteria evaluating the importance and feasibility of conducting potential real-world evidence (RWE) studies aimed at addressing uncertainties stemming from initial cancer drug funding recommendations. In collaboration with the Canadian Agency for Drugs and Technologies in Health's Provinci...
Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Pam Takhar Marc Geirnaert Scott Gavura Jaclyn Beca Rebecca E Mercer Avram Denburg Caroline Mu ñoz Mina Tadrous Ambica Parmar Francois Dionne Darryl Boehm Carole Chambers Erica Craig Maureen Trudeau Matthew C Cheung Joanne Houlihan Valerie McDonald Petros Source Type: research
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
Curr Oncol. 2024 Mar 29;31(4):1803-1816. doi: 10.3390/curroncol31040136.ABSTRACTPatient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, health technology assessment (HTA) and collective government price negotiation. These steps delay access and prevent health care providers from being able to prescribe optimal therapy. Eighteen Canadian oncology clinicians from the medicine, nursing and pharmacy professions met to develop consensus recommendations for defining reasonable government performance standards around process and ti...
Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Sandeep R Sehdev Nigel S B Rawson Olexiy I Aseyev Catriona J Buick Marcus O Butler Scott Edwards Sharlene Gill Joanna M Gotfrit Cyrus C Hsia Rosalyn A Juergens Mita Manna Joy S McCarthy Som D Mukherjee Stephanie L Snow Silvana Spadafora David J Stewart Ja Source Type: research
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141.ABSTRACTMulti-criteria decision analysis (MCDA) is a value assessment tool designed to help support complex decision-making by incorporating multiple factors and perspectives in a transparent, structured approach. We developed an MCDA rating tool, consisting of seven criteria evaluating the importance and feasibility of conducting potential real-world evidence (RWE) studies aimed at addressing uncertainties stemming from initial cancer drug funding recommendations. In collaboration with the Canadian Agency for Drugs and Technologies in Health's Provinci...
Source: Current Oncology - April 26, 2024 Category: Cancer & Oncology Authors: Pam Takhar Marc Geirnaert Scott Gavura Jaclyn Beca Rebecca E Mercer Avram Denburg Caroline Mu ñoz Mina Tadrous Ambica Parmar Francois Dionne Darryl Boehm Carole Chambers Erica Craig Maureen Trudeau Matthew C Cheung Joanne Houlihan Valerie McDonald Petros Source Type: research
